The Ugandan Academy for Health Innovation and Impact was formed after a Memorandum of Understanding (MoU) was undertaken between the: Ministry of Health, Infectious Diseases Institute (IDI), Janssen, the pharmaceutical companies of Johnson & Johnson, and the Johnson & Johnson Corporate Citizenship Trust. Housed within the IDI-McKinnell Knowledge Centre, Makerere University, the Academy is the first flagship implementation of Connect for Life™ – a collaborative program to empower healthcare workers, academics and patients to address critical health challenges, including HIV, TB, and maternal and child health in resource limited settings.
As 2018 marked the mid-point of our Janssen funding, we undertook a planned an mid-term evaluation our 5-year strategic plan. The aim was to document the achievements realized so far, identify gaps and challenges as well as determine the focus areas for the remaining period of the plan.
Key findings;
Funding for sub-granting will be coming to an end year 5. In the current funding environment, HIV and TB funding is not certain after the 5 years of the current strategic PEPFAR plan.
Key strengths include;
Ability to mobilize/source funds and fund local organizations, strong grants management structures, experience in working with sub-grantees, ability to innovate and facilitate innovations
Key strategies moving forward
- Broaden the resource mobilization and funding base for the remaining plan period and beyond.
- Develop a mechanism for choosing new projects in order to emphasize priority innovation areas with traditional funders (research organizations, large multinational agencies, etc).
- Develop a network of interested partners who benefit from Academy services, including the Health Innovations Conference.
- Work with Janssen GPH to develop a value proposition to attract non-traditional funds (e.g. corporate CSR) for continuing to support Sub-granting activities.
Please see Downloads for the Full 2018-2019 Annual Report